Skip to main content

Table 1 Demographic, cardiovascular and health variables for Maine-Syracuse Longitudinal Study (N = 970) participants according to metabolic syndrome status

From: Association between depressive symptoms, use of antidepressant medication and the metabolic syndrome: the Maine-Syracuse Study

  MetS  
Variable No Yes P-value
n = 539 n = 431
  M or % SD M or % SD  
Age, years 60.7 13.4 63.7 11.9 <0.001
Gender      0.1
 Males 38.8   43.9   
 Females 61.2   56.1   
Education, years 15.1 2.6 14.1 2.7 <0.001
Race      0.019
 Caucasian 94.2   90.3   
 African American 5.8   9.7   
Smoking, no cigarettes/day 1.0 4.2 1.8 6.4 0.027
BMI, kg/m2 27.1 4.5 32.1 6.2 <0.001
Physical activity, MET mins/daya 1517 1803 880 1370 <0.001
Total cholesterol, mg/dL 204.8 37.1 197.0 42.2 0.002
HDL cholesterol, mg/dL 59.2 5.2 46.7 12.4 <0.001
LDL cholesterol, mg/dL 125.8 32.0 114.5 33.8 <0.001
Systolic BP, mmHg 124.8 21.0 138.5 19.9 <0.001
Diastolic BP, mmHg 68.6 9.9 72.8 9.7 <0.001
Fasting blood glucose, mg/dL 90.6 15.4 109.5 35.9 <0.001
Waist circumference, cm 88.8 12.4 103.6 14.0 <0.001
CRP, mg/L 0.36 0.43 0.52 0.53 <0.001
Triglycerides, mg/dL 101.9 47.0 192.4 143.3 <0.001
Alcohol intake, g/week 41.6 74.6 29.2 62.3 0.006
Depressed mood, CES-D scoreb 6.8 6.4 8.5 7.3 <0.001
Depressed mood, Zung scoreb 41.1 8.5 43.8 10.1 <0.001
% using antidepressants 8.3   15.1   0.001
% Obese (BMI ≥ 30 kg/m2) 20.8   61.4   <0.001
% Diabetes mellitusc 2.0   25.5   <0.001
% Hypertensiond 40.8   87.5   <0.001
% CVDe 8.0   22.0   <0.001
% APOE ε4 26.9   27.0   0.9
  1. APOE ε4 apolipoprotein ε4, BMI body mass index, BP blood pressure, CES-D Center for Epidemiologic Studies Depression Scale, CRP C-reactive protein, CVD cardiovascular disease, MetS metabolic syndrome, MET metabolic equivalent, MSLS Maine-Syracuse Longitudinal Study
  2. aIncludes moderate and intense self-reported physical activity
  3. bHigher scores indicates greater number of depressive symptoms
  4. cFasting plasma glucose ≥ 126 mg/dL or taking anti-diabetic medication
  5. dSystolic BP ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg or taking anti-hypertensive medication
  6. eIncludes myocardial infarction, coronary artery disease, heart failure, angina pectoris, transient ischemic attack
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us